Sort
8,912 grants matching “sars cov 2”
Pathogenesis of myalgia and fatigue after SARS-CoV-2 infection
$145,723Sachiko Homma · Boston University Medical Campus · R21 · FY2023 · AR
Core C - Modeling Core
$145,618Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U19 · FY2025 · AI
The effect of HIV on SARS-CoV-2 transmission and emergence of variants of concern
$145,607Sanghyuk Sam Shin · University Of California-Irvine · R01 · FY2024 · AI
SARS-CoV-2 Pathogenesis
$145,518Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Understanding the effects of COVID-19 on maternal substance use
$145,460Julie May Croff · Osu Center For Health Sciences · R34 · FY2020 · DA
Molecular Mechanisms of SARS-CoV-2 Infection and Therapeutic Targets
$144,905Helen Su · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
EAGER-Harnessing natural killer cell-derived extracellular vesicles as anti-viral nanomaterials
$144,647Eun Ji Chung · University Of Southern California · · FY2021 · MPS
Immune phenotyping of human immune responses to SARS CoV-2 vaccination and infection
$144,279Florian Krammer · Icahn School Of Medicine At Mount Sinai · U19 · FY2025 · AI
Scientific Project 2: HIV AIDS Defining molecular signatures in humans following vaccination that can inform pathways to protective immunity against HIV-1 infection
$144,133Margaret Juliana McElrath · Seattle Children'S Hospital · U19 · FY2024 · AI
The impact of prenatal maternal infection and inflammation on human brain development and psychopathology during adolescence
$143,589Veerle Bergink · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · MH
Host Substrate Profiling of SARS-CoV-2 Virus Protease
$143,427Ronak R Tilvawala · University Of Kansas Lawrence · P20 · FY2020 · GM
RAPID: Combined Antigen and Serology Rapid Test for COVID-19
$143,204Ashutosh Chilkoti · Duke University · · FY2020 · ENG
The COVID-19 vaccine efficacy among people living with and without HIV: a real-world data approach
$143,171Xueying Yang · University Of South Carolina At Columbia · R21 · FY2023 · AI
Human monoclonal antibodies against SARS-CoV-2
$143,050Joshua Hoong Yu Tan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Evaluation of Oropharyngeal responses to SARS-CoV-2
$143,034Pamela Schwartzberg · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Urinary Exosomes and COVID-19
$142,521Mark Knepper · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
IMPROVING COVID-19 VACCINATION UPTAKE IN HIV POSITIVE PREGNANT WOMEN IN NIGERIA
$142,199Alash'le G. Abimiku · Institute Of Human Virology · U01 · FY2022 · HD
Identification of the HIV Reservoir in Lymph Nodes Using Single Cell RNA-Seq
$141,941Alexander Sigal · Kwazulu-Natal Research Institute Tb-Hiv · R01 · FY2022 · AI
Regeneration of the Immune System after Radiation Exposure
$141,834Chandan Guha · Albert Einstein College Of Medicine · U01 · FY2024 · AI
Project 3: Responding to Changing Serological and Viral Information around COVID-19 (RESPOND)
$141,622Ann Scheck McAlearney · Ohio State University · U54 · FY2022 · CA
Innate Immune Regulation of the Epithelium in Chronic Rhinosinusitis with Nasal Polyps
$141,446Andrew P Lane · Johns Hopkins University · R01 · FY2020 · AI
Mechanisms of antibody-dependent enhancement of SARS-CoV-2 infection
$141,249Stylianos Bournazos · Rockefeller University · R01 · FY2020 · AI
RAPID: COVID-19 diagnostics for limited resource settings via improved sample preparation
$140,939Rustem F Ismagilov · California Institute Of Technology · · FY2020 · ENG
Impact of SARS-CoV-2 infection on reactivation of latent Mtb infections in a Kenyan Cohort
$140,534Jesse Gitaka · Mount Kenya University · R01 · FY2022 · AI
Personalized small molecule therapy for severe asthma and cystic fibrosis.
$140,306Benjamin M Gaston · Indiana University Indianapolis · P01 · FY2020 · HL